A Safety and Effectiveness Study of Vaccine Therapy in Patients With Indolent Lymphoma
Trial details
- Registry ID
- NCT00081809
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Safety and Effectiveness Study of Vaccine Therapy in Patients With Indolent LymphomaNCT00081809 | AGEN | Phase 2 | Completed | 2005-06Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |